New Rules for Pandemic CPR; HF-Cancer Link; Post-TAVR Infective Endocarditis Tx
— Recent developments of interest in cardiovascular medicine
by Nicole Lou, Staff Writer, MedPage Today January 25, 2022
In a guidance update, the American Heart Association (AHA) said healthcare providers should quickly don PPE before performing CPR on people with suspected COVID-19. (Circulation: Cardiovascular Quality and Outcomes)
A small risk of carditis associated with the Pfizer COVID-19 vaccine was supported by a case-control study from Hong Kong comparing the mRNA vaccine against an inactivated virus vaccine. (Annals of Internal Medicine)
Israeli cardiologist Dror Mevorach, MD, says it took 4 months for his team to convince Pfizer that its COVID-19 vaccine carried a risk of myocarditis. (Haaretz)
As in the case of anterior circulation stroke, faster endovascular treatment for basilar artery occlusion stroke was tied to better outcomes for patients in a U.S. registry. (Circulation)
The FINGER lifestyle intervention brought down cerebrovascular events, in addition to cognition events, in older adults. Coronary events were also down in those with a history of cardiovascular disease. (European Heart Journal)
The various definitions of iron deficiency muddy the waters of what true iron deficiency does to patients with heart failure and its treatment. (Journal of the American College of Cardiology)
Heart failure was associated with an increased risk of subsequent cancer in an Italian community study. (JACC: CardioOncology)
Heart failure care remains pricey, according to an economic analysis by the Heart Failure Society of America. (Journal of Cardiac Failure)
Since the heart allocation policy change in 2018, centers sharing the same organ procurement organization can still have big differences in likelihood of transplant. (JAMA Cardiology)
In a Canadian study, pregnant women at higher risk of preeclampsia were unlikely to follow recommendations to take aspirin. (JAMA)
Infective endocarditis after transcatheter aortic valve replacement was rarely treated with surgery, which offered no survival advantage over medical management alone, a national database study showed. (Catheterization & Cardiovascular Interventions)
The Biotres cardiac monitoring holter device received FDA 510(k) clearance, manufacturer Biotricity announced.
The FDA warned that Medtronic’s HawkOne Directional Atherectomy System is under Class I recall due to potential separation of the catheter tip as a result of problems with the guidewire.
This summer, hospitals may seek Comprehensive Heart Attack Center certification from the AHA and Joint Commission.
A new guideline on managing type B aortic dissection highlighted earlier endovascular treatment, such as thoracic endovascular aortic repair. (Annals of Thoracic Surgery)
Research suggested better safety with oral penicillin versus intramuscular injection for the treatment of severe rheumatic heart disease. (Journal of the American Heart Association)
A Mendelian randomization study suggested that blocking the inflammatory cytokine TNF may not do much for preventing coronary artery disease or ischemic stroke. (eBioMedicine)
Can HIF-1α, a master transcriptional regulator of tissue hypoxia, protect people from COVID-associated cardiac dysfunction? (JACC: Basic to Translational Science)
A profile on identical twins both working as ultrasound cardiology technologists at Pennsylvania Hospital. (Philadelphia Inquirer)